10x Genomics Inc. (TXG)

Illumina Inc. (ILMN $99.25)
- $99.25 Cap: $15.71B
- View ILMN Profile
- View Questions on ILMN
Pacific Biosciences of California Inc. (PACB $1.47)
- $1.47 Cap: $444M
- View PACB Profile
- View Questions on PACB
CRISPR Therapeutics AG (CRSP $56.80)
- $56.80 Cap: $4.90B
- View CRSP Profile
- View Questions on CRSP
Bio-Techne Corp (TECH $54.14)
- $54.14 Fwd P/E: 65.23X Cap: $8.24B
- View TECH Profile
- View Questions on TECH
10x Genomics Inc. (TXG $12.80)
- $12.80 Cap: $1.57B
- View TXG Profile
- View Questions on TXG

Q: Can you recommend stocks or ETFs in Multiomic sequencing

Read Answer Asked by Danielle on June 17, 2025

Parex Resources Inc. (PXT $14.59)
- $14.59 Fwd P/E: 13.18X Cap: $1.42B
- View PXT Profile
- View Questions on PXT
Cal-Maine Foods Inc. (CALM $100.52)
- $100.52 Fwd P/E: 4.97X Cap: $4.93B
- View CALM Profile
- View Questions on CALM
Clairvest Group Inc. (CVG $75.41)
- $75.41 Fwd P/E: 13.07X Cap: $1.10B
- View CVG Profile
- View Questions on CVG
Kulicke and Soffa Industries Inc. (KLIC $36.26)
- $36.26 Fwd P/E: 99.89X Cap: $1.91B
- View KLIC Profile
- View Questions on KLIC
Dundee Precious Metals Inc. (DPM $22.49)
- $22.49 Fwd P/E: 12.48X Cap: $3.77B
- View DPM Profile
- View Questions on DPM
Hollysys Automation Technologies Ltd. (HOLI)
- Cap: $1.63B
- View HOLI Profile
- View Questions on HOLI
Mueller Industries Inc. (MLI $86.39)
- $86.39 Fwd P/E: 15.74X Cap: $9.38B
- View MLI Profile
- View Questions on MLI
Encore Wire Corporation (WIRE)
- Fwd P/E: 15.22X Cap: $4.57B
- View WIRE Profile
- View Questions on WIRE
10x Genomics Inc. (TXG $12.80)
- $12.80 Cap: $1.57B
- View TXG Profile
- View Questions on TXG
Coveo Solutions Inc. Subordinate voting shares (CVO $7.63)
- $7.63 Cap: $733M
- View CVO Profile
- View Questions on CVO

Q: I am looking for cash-rich stocks with unusually low prices at the moment.

Could you recommend 5 Canadian and 5 US stocks

Thanks

0

Read Answer Asked by V on April 13, 2023

Exact Sciences Corporation (EXAS $51.91)
- $51.91 Cap: $9.79B
- View EXAS Profile
- View Questions on EXAS
Invitae Corporation (NVTA)
- Cap: $5M
- View NVTA Profile
- View Questions on NVTA
CRISPR Therapeutics AG (CRSP $56.80)
- $56.80 Cap: $4.90B
- View CRSP Profile
- View Questions on CRSP
Guardant Health Inc. (GH $50.25)
- $50.25 Cap: $6.22B
- View GH Profile
- View Questions on GH
Twist Bioscience Corporation (TWST $38.03)
- $38.03 Cap: $2.27B
- View TWST Profile
- View Questions on TWST
Intellia Therapeutics Inc. (NTLA $11.54)
- $11.54 Cap: $1.19B
- View NTLA Profile
- View Questions on NTLA
10x Genomics Inc. (TXG $12.80)
- $12.80 Cap: $1.57B
- View TXG Profile
- View Questions on TXG
DermTech Inc (DMTK)
- Cap: $3M
- View DMTK Profile
- View Questions on DMTK

Q: Looking at companies in these companies, some have more current business (EXAS) while others are based more on potential. Can you please rank each in order based on these two approaches:

1. Most growth potential
2. Best overall investment

Please comment briefly on why you would place a particular company as "Best in class" for approach 1 and 2.

0

Read Answer Asked by Tim on April 05, 2022